Publications and communications of Antoine BOUQUEGNEAU

Cavalier, E., Farre Segura, J., LUKAS, P., GENDEBIEN, A.-S., Peeters, S., Massonnet, P., Le Goff, C., Bouquegneau, A., Souberbielle, J.-C., Delatour, V., & Delanaye, P. (2023). Unveiling a new era with liquid chromatography coupled with mass spectrometry to enhance parathyroid hormone measurement in patients with chronic kidney disease. Kidney International. doi:10.1016/j.kint.2023.09.033

Fank, H.* , Weekers, L.* , Lovinfosse, P.* , Pottel, H., Seidel, L., Jadoul, A., Bouquegneau, A., BONVOISIN, C., Bovy, C., GROSCH, S., Erpicum, P., Hustinx, R., & Jouret, F. (25 August 2023). The uptake of [18F]-fluorodeoxyglucose by the renal allograft correlates with the acute Banff scores of cortex inflammation but not with the 1-year graft outcomes. Frontiers in Transplantation, 2. doi:10.3389/frtra.2023.1236751
* These authors have contributed equally to this work.

Masson, G., Viva, T., Huart, J., Weekers, L., BONVOISIN, C., Bouquegneau, A., MAWEJA, S., Hamoir, E., Seidel, L., Pottel, H., Lancellotti, P., & Jouret, F. (01 August 2023). The Effect of Elective Ligation of the Arteriovenous Fistula on Cardiac and Renal Functions in Kidney Transplant Recipients. Kidney360, 4 (8), 1130 - 1138. doi:10.34067/KID.0000000000000198

Mariat, C., Gaillard, F., Fournier, T., Rabate, C., Pincon, É., Bacchetta, J., Aurelle, M., & Bouquegneau, A. (26 April 2023). Pourquoi développer la greffe de rein à partir de donneurs vivants en France en 2023 ? Néphrologie et Thérapeutique, 19 (2), 83 - 88. doi:10.1684/ndt.2023.20

Erpicum, P., Pinto Coelho, T., BONVOISIN, C., Bouquegneau, A., GROSCH, S., Navez, M., Vandermeulen, M., Beguin, Y., Detry, O., Jouret, F., & WEEKERS, L. (February 2023). Reprise retardée de fonction du greffon après transplantation rénale : un challenge clinique toujours d’actualité. Revue Médicale de Liège, 78 (2), 107 - 113.

Al-Awadhi, S., Raynaud, M., Louis, K., Bouquegneau, A., Taupin, J.-L., Aubert, O., Loupy, A., & Lefaucheur, C. (2023). Complement-activating donor-specific anti-HLA antibodies in solid organ transplantation: systematic review, meta-analysis, and critical appraisal. Frontiers in Immunology, 14, 1265796. doi:10.3389/fimmu.2023.1265796

Ancion, A., Poirrier, A.-L., Dessard Laura, Detrembleur, N., Bouquegneau, A., Lepage Pierre, Duran, U., Reuter, G., Lefèbvre, P., & Rogister, F. (2023). Rhino-Sinusal Mucormycosis: About the Management of 2 Clinical Cases. B-ENT. doi:10.5152/B-ENT.2023.22942

Delanaye, P., Lanot, A., Bouquegneau, A., Warling, X., Radermacher, L., Masset, C., Krzesinski, J.-M., Moranne, O., & Cavalier, E. (January 2023). Monitoring 25-OH and 1,25-OH vitamin D levels in hemodialysis patients after starting therapy: Does it make sense? Clinica Chimica Acta, 539, 50-54. doi:10.1016/j.cca.2022.11.032

TIV, H., Vandelaer, A., Delanaye, P., Forte, F., & Bouquegneau, A. (December 2022). Piège diagnostique : neurotoxicité au lithium avec lithémie normale. Néphrologie et Thérapeutique, 18 (7), 650 - 654. doi:10.1016/j.nephro.2022.07.398

Donker, E. M., Bet, P., Nurmohamed, A., Serné, E., Burchell, G. L., Friedman, A. N., Bouquegneau, A., Lemoine, S., Ebert, N., Cirillo, M., van Agtmael, M. A., & Bartelink, I. H. (September 2022). Estimation of glomerular filtration rate for drug dosing in patients with very high or low body mass index. Clinical and Translational Science, 15 (9), 2206 - 2217. doi:10.1111/cts.13354

BOUQUEGNEAU, A., MALAISE, O., SEIDEL, L., BONVOISIN, C., WEEKERS, L., JOURET, F., CAVALIER, E., & DELANAYE, P. (May 2022). Bone Mineral Density, Bone Micro-Architecture Evolution After Kidney Transplantation: A Prospective Cohort Study. Nephrology Dialysis Transplantation, 37 (Supplement_3). doi:10.1093/ndt/gfac073.006

ERPICUM, P., BONVOISIN, C., GROSCH, S., BOVY, C., Pinto Coelho, T., DETRY, O., JOURET, F., WEEKERS, L., & BOUQUEGNEAU, A. (May 2022). Diagnostic et prise en charge thérapeutique du rejet en transplantation rénale. Revue Médicale de Liège, 77 (5-6), 338-344.

GROSCH, S., ERPICUM, P., BOUQUEGNEAU, A., JOURET, F., & BOVY, C. (May 2022). Le glomérule dans tous ses états. Revue Médicale de Liège, 77 (5-6), 330-337.

DELANAYE, P., Cavalier, E., & Bouquegneau, A. (2022). The ideal drug dosage adaptation through estimated glomerular filtration rate in obese patients? Measuring GFR is the key. British Journal of Clinical Pharmacology. doi:10.1111/bcp.15255

Firket, L., Descy, J., Seidel, L., Bonvoisin, C., Bouquegneau, A., Grosch, S., Jouret, F., & Weekers, L. (November 2021). Serological response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients depends on prior exposure to SARS-CoV-2. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 21 (11), 3806-3807. doi:10.1111/ajt.16726

Nakanishi, T., Pigazzini, S., Degenhardt, F., Cordioli, M., Butler-Laporte, G., Maya-Miles, D., Nafría-Jiménez, B., Bouysran, Y., Niemi, M., Palom, A., Ellinghaus, D., Khan, A., Martínez-Bueno, M., Rolker, S., Amitano, S., Tato, L. R., Fava, F., Spinner, C. D., Prati, D., ... consortium, C.-H. (October 2021). Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality. Journal of Clinical Investigation, Online ahead of print.. doi:10.1172/JCI152386

HUART, J., BOUQUEGNEAU, A., Lutteri, L., ERPICUM, P., GROSCH, S., Résimont, G., WIESEN, P., BOVY, C., Krzesinski, J.-M., THYS, M., LAMBERMONT, B., Misset, B., Pottel, H., Mariat, C., CAVALIER, E., Burtey, S., Jouret, F., & DELANAYE, P. (23 January 2021). Proteinuria in COVID‑19: prevalence, characterization and prognostic role. Journal of Nephrology, 34 (3), 355-364. doi:10.1007/s40620-020-00931-w

BOUQUEGNEAU, A., HUART, J., LUTTERI, L., ERPICUM, P., GROSCH, S., Résimont, G., WIESEN, P., ROUSSEAU, A.-F., BOVY, C., KRZESINSKI, J.-M., THYS, M., LAMBERMONT, B., Misset, B., Pottel, H., DARCIS, G., CAVALIER, E., JOURET, F., & DELANAYE, P. (2021). Survivors of COVID-19 mostly recover from tubular proteinuria and acute kidney injury after hospital discharge. Journal of Nephrology, 34 (4), 967-969. doi:10.1007/s40620-021-01075-1

DELANAYE, P., HUART, J., BOUQUEGNEAU, A., & JOURET, F. (2021). Long-term effects of COVID-19 on kidney function [letter to the editor]. The Lancet, 397 (10287), 1807. doi:10.1016/S0140-6736(21)00881-3

LOVINFOSSE, P., Weekers, F., Pottel, H., BOUQUEGNEAU, A., BONVOISIN, C., BOVY, C., GROSCH, S., Hustinx, R., & Jouret, F. (2021). [(18)F]FDG PET/CT imaging disproves renal allograft acute rejection in kidney transplant recipients with acute kidney dysfunction: a validation cohort. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-021-05467-0

Maisons, V., Garnier, A.-S., Lohéac, C., Bouquegneau, A., Goubella, A., Hocine, A., & Bobot, M. (2021). Letter Regarding "Impact of the COVID-19 Pandemic on Training and Well-Being of Nephrology Residents in France and Belgium". Kidney International Reports. doi:10.1016/j.ekir.2021.12.035

Reese, P. P., Aubert, O., Naesens, M., Huang, E., Potluri, V., Kuypers, D., Bouquegneau, A., Divard, G., Raynaud, M., Bouatou, Y., Vo, A., Glotz, D., Legendre, C., Lefaucheur, C., Jordan, S., Empana, J.-P., Jouven, X., & Loupy, A. (2021). Assessment of the Utility of Kidney Histology as a Basis for Discarding Organs in the United States: A Comparison of International Transplant Practices and Outcomes. Journal of the American Society of Nephrology : JASN, 32 (2), 397-409. doi:10.1681/ASN.2020040464

ERPICUM, P., GROSCH, S., BOUQUEGNEAU, A., HUART, J., Résimont, G., BOVY, C., HABRAN, L., Delvenne, P., KRZESINSKI, J.-M., BURTEY, S., DELANAYE, P., & Jouret, F. (2020). Atteintes rénales de la COVID-19. Revue Médicale de Liège. Supplément, 75 (supplément 1), 109-S114.

BOUQUEGNEAU, A., Evenepoel, P., PAQUOT, F., MALAISE, O., CAVALIER, E., & DELANAYE, P. (2019). Sclerostin within the chronic kidney disease spectrum. Clinica Chimica Acta, 502, 84-90. doi:10.1016/j.cca.2019.12.008

Loupy, A., Bouquegneau, A., Stegall, M. D., & Montgomery, R. A. (2019). Clinical outcomes after ABO-incompatible renal transplantation. Lancet (London, England), 394 (10213), 1988-1989. doi:10.1016/S0140-6736(19)32490-0

BOUQUEGNEAU, A., Loheac, C., Aubert, O., Bouatou, Y., Viglietti, D., Empana, J. P., Ulloa, C., Hassan Murad, M., Legendre, C., Glotz, D., Jackson, A. M., Zeevi, A., Schaub, S., Taupin, J. L., Reed, E. F., Friedewald, J. J., Tyan, D. B., Süsal, C., Shapiro, R., ... Loupy, A. (2018). Complement-activating donor-specific anti-HLA antibodies and solid organ transplant survival: A systematic review and meta-analysis. PLoS Medicine, 15 (5). doi:10.1371/journal.pmed.1002572

DELANAYE, P., Guerber, F., SCHEEN, A., Ellam, T., BOUQUEGNEAU, A., Guergour, D., Mariat, C., & Pottel, H. (February 2017). Discrepancies between the Cockcroft–Gault and Chronic Kidney Disease Epidemiology (CKD-EPI) Equations: Implications for Refining Drug Dosage Adjustment Strategies. Clinical Pharmacokinetics, 56 (2), 193-205. doi:10.1007/s40262-016-0434-z

JADOT, V., Krzesinski, J.-M., VON FRENCKELL, C., BOVY, C., & BOUQUEGNEAU, A. (2017). La néphropathie lupique : les nouvelles perspectives de traitement. Néphrologie et Thérapeutique, 14, 1-12. doi:10.1016/j.nephro.2017.05.002

BOUQUEGNEAU, A., Salam, S., DELANAYE, P., Eastell, R., & Khwaja, A. (2016). Bone disease after kidney transplantation. Clinical Journal of the American Society of Nephrology, 11 (7), 1282-1296. doi:10.2215/CJN.11371015

BOUQUEGNEAU, A., Vidal-Petiot, E., Moranne, O., Mariat, C., Boffa, J., Vrtovsnik, F., SCHEEN, A., KRZESINSKI, J.-M., Flamant, M., & DELANAYE, P. (2016). Creatinine-based equations for the adjustment of drug dosage in an obese population. British Journal of Clinical Pharmacology, 81 (2), 349-361. doi:10.1111/bcp.12817

BOUQUEGNEAU, A., Vidal-Petiot, E., Vrtovsnik, F., Moranne, O., Flamant, M., & DELANAYE, P. (2015). Equations basées sur la créatinine pour l’adaptation posologique des médicaments dans une population de patients obèses [Poster presentation]. XVII réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Lyon, France.

BOUQUEGNEAU, A., Vidal-Petiot, E., Vrtovsnik, F., CAVALIER, E., KRZESINSKI, J.-M., Flamant, M., & DELANAYE, P. (2014). Accuracy of Cockcroft&Gault and CKD-EPI equations to estimate glomerular filtration rate in obese population [Poster presentation]. LI Congress of ERA-EDTA, Amsterdam, Netherlands.

BOUQUEGNEAU, A., Vidal-Petito, E., Vrtovsnik, F., CAVALIER, E., KRZESINSKI, J.-M., Flamant, M., & DELANAYE, P. (2014). Cockcroft&Gault and CKD-EPI equations: are these equations concordant to adjust drug dosage? [Poster presentation]. LI Congress of ERA-EDTA, Amsterdam, Netherlands.

BOUQUEGNEAU, A., CAVALIER, E., Krzesinski, J.-M., & DELANAYE, P. (18 April 2013). MDRD VERSUS CKD-EPI EQUATIONS TO ESTIMATE GLOMERULAR FILTRATION RATE IN OBESE PATIENTS [Poster presentation]. 50th ERA-EDTA Congress, Istanbul, Turkey.

Benoit, A., BOUQUEGNEAU, A., PETROSSIANS, P., & Beckers, A. (2013). Malabsorption des hormones thyroïdiennes... ou simple manque de compliance ? Revue Médicale de Liège, 68 (3), 118-121.

Vidal-Petiot, E., DELANAYE, P., BOUQUEGNEAU, A., Vrtovsnik, F., CAVALIER, E., & Flamant, M. (2013). Estimation du débit de filtration glomérulaire chez l’obèse : MDRD ou CKD-EPI ? [Poster presentation]. XV réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Nantes, France.

DELANAYE, P., BOUQUEGNEAU, A., DUBOIS, B., & ANDRE, B. (2012). Le médicament du mois : Fébuxostat (Adenuric®). Revue Médicale de Liège, 67 (4), 202-209.

BOUQUEGNEAU, A., Longton, J., Bovy, C., & Krzesinski, J.-M. (2010). La néphropathie tubulo-interstitielle aiguë: une cause rare d’insuffisance rénale aiguë. Revue Médicale de Liège, 65 (7-8), 459-463.